Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 63 (7), 332-336
- https://doi.org/10.1007/bf01731977
Abstract
The effects of orally administered glandular kallikrein on urinary kallikrein, aldosterone and prostaglandin E (PGE) excretion, plasma renin activity (PRA), immunoreactive 6-keto PGF1α and thromboxane B2 concentrations and platelet aggregation were studied in 12 patients with essential hypertension (EH). After a 2-week control period, each patient was given orally 450 KU/day of hog glandular kallikrein for 8 weeks. Urinary kallikrein, aldosterone and PGE excretion, and plasma 6-keto PGF1α and thromboxane B2 concentrations were measured by radio-immunoassay. Platelet aggregation was measured by the addition of ADP, collagen or ristocetin with an aggregometer. Urinary kallikrein excretion and plasma 6-keto PGF1α concentration were significantly decreased in patients with EH. There were no significant differences in PRA, urinary aldosterone excretion and plasma thromboxane B2 concentrations between control subjects and patients with EH. There was a significant decrease in blood pressure in patients with EH coinciding with significant increases of urinary kallikrein and PGE excretion and plasma immunoreactive 6-keto PGF1α concentration after administration of glandular kallikrein. There was also a significant inhibition of platelet aggregation induced by collagen in these patients. Thus, a suppression of the kallikrein-kinin-prostaglandin system in patients with EH was found, and a decrease in blood pressure with an increment of urinary kallikrein, PGE excretion, plasma immunoreactive 6-keto PGF1α and inhibition of platelet aggregation in vivo by the administration of glandular kallikrein.Keywords
This publication has 19 references indexed in Scilit:
- Kallikrein stimulates prostacyclin production in bovine vascular endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Plasma concentrations of 6-keto-prostaglandin F1.ALPHA., thromboxane B2 and platelet aggregation in patients with essential hypertension.Japanese Heart Journal, 1984
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983
- Plasma levels of 6-keto-prostaglandin F1α in normotensive subjects and patients with essential hypertensionProstaglandins, Leukotrienes and Medicine, 1983
- Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertensionKlinische Wochenschrift, 1980
- Relationships between the kallikrein-kinin and prostaglandin systemsLife Sciences, 1979
- The renal kallikrein-kinin system in human and in experimental hypertensionKlinische Wochenschrift, 1978
- ALTERED URINARY KALLIKREIN EXCRETION IN HUMAN HYPERTENSIONThe Lancet, 1971
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- Der Kallikreingehalt des Harns, des Speichels und des Blutes bei Gesunden und KrankenClinical and Experimental Medicine, 1938